Aspirin, Risk of Colorectal Cancer, & Genetic Risk—Reply

Andrew Bakshi; Andrew T. Chan

doi:10.1158/1940-6207.CAPR-22-0235

Aspirin, Risk of Colorectal Cancer, & Genetic Risk—Reply

Andrew Bakshi
, Andrew T. Chan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	703
Number of pages	1
Journal	Cancer Prevention Research
Volume	15
Issue number	10
DOIs	https://doi.org/10.1158/1940-6207.CAPR-22-0235
State	Published - Oct 2022
Externally published	Yes

Access to Document

10.1158/1940-6207.CAPR-22-0235

Cite this

@article{75871361b00243279a4bd7545592e0ea,

title = "Aspirin, Risk of Colorectal Cancer, \& Genetic Risk—Reply",

author = "Andrew Bakshi and Chan, \{Andrew T.\}",

note = "Funding Information: A.T. Chan reports personal fees from Bayer Pharma AG, Boehringer Ingelheim; grants and personal fees from Pfizer Inc.; and grants from Zoe, Ltd. outside the submitted work. No disclosures were reported by the other author.",

year = "2022",

month = oct,

doi = "10.1158/1940-6207.CAPR-22-0235",

language = "English",

volume = "15",

pages = "703",

journal = "Cancer Prevention Research",

issn = "1940-6207",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Aspirin, Risk of Colorectal Cancer, & Genetic Risk—Reply

AU - Bakshi, Andrew

AU - Chan, Andrew T.

N1 - Funding Information: A.T. Chan reports personal fees from Bayer Pharma AG, Boehringer Ingelheim; grants and personal fees from Pfizer Inc.; and grants from Zoe, Ltd. outside the submitted work. No disclosures were reported by the other author.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85139136692

U2 - 10.1158/1940-6207.CAPR-22-0235

DO - 10.1158/1940-6207.CAPR-22-0235

M3 - Letter

C2 - 36193656

AN - SCOPUS:85139136692

SN - 1940-6207

VL - 15

SP - 703

JO - Cancer Prevention Research

JF - Cancer Prevention Research

IS - 10

ER -